Literature DB >> 35815172

Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis.

Ahmed Naguy1, Suliman Al-Khadhari1, Saxby Pridmore1.   

Abstract

This case is one of the earliest to report on lurasidone-related QTc prolongation in a dose-dependent fashion in CAP population at therapeutic doses. Although these reports remain scarce, it behoves prescribers to be vigilant and mindful of these unusual but serious side effects especially in setting of cumulative risks.
Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.

Entities:  

Keywords:  FEP; QTc; adolescent; lurasidone

Mesh：

Substances：

Year:  2022        PMID： 35815172      PMCID： PMC9235318     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


  5 in total

Review 1.  Lurasidone: a clinical overview.

Authors:  John M Kane
Journal:  J Clin Psychiatry       Date:  2011       Impact factor: 4.384

2.  Probable Bupropion-Related QTc Prolongation in an Adolescent With Major Depressive Disorder.

Authors:  Ahmed Naguy; Bibi Alamiri
Journal:  Am J Ther       Date:  2020-08-03       Impact factor: 2.688

Review 3.  Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.

Authors:  D L Kelly; R C Love
Journal:  Psychopharmacol Bull       Date:  2001

4.  Aripiprazole cardiosafety: Is it overestimated?

Authors:  Ahmed Naguy
Journal:  J Family Med Prim Care       Date:  2016 Jul-Sep

5.  Psychotropic Drugs and Prolonged QTc Interval: Does it Really that Matter?

Authors:  Ahmed Naguy
Journal:  Indian J Psychol Med       Date:  2016 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.